Home
About Us
Leadership Team
news
Careers
facility
Contact Us
news
Careers
facility
Contact Us
Home
About Us
Leadership Team
CAREERS
You are here
Home
» News
News
THERAPURE INNOVATIONS RECEIVES FDA APPROVAL TO PROCEED WITH A PHASE 1 CLINICAL TRIAL OF THE TARGETED LIVER CANCER THERAPEUTIC TBI 302
05/21/2015
Therapure Biomanufacturing Receives Four CMO Leadership Awards in Quality, Reliability, Productivity and Regulatory Categories
03/20/2015
Therapure Biomanufacturing Receives Four CMO Leadership Awards in Quality, Reliability, Productivity and Regulatory Categories
03/20/2015
THERAPURE INNOVATIONS RECEIVES FDA APPROVAL TO PROCEED WITH A PHASE 1 CLINICAL TRIAL OF ITS NOVEL ANEMIA THERAPEUTIC TBI 304H
03/13/2015
Therapure Biopharma Inc. Ranks within the Top 5% on the 2014 PROFIT 500 List of the Fastest Growing Companies in Canada
06/13/2014
Therapure Biomanufacturing Awarded Manufacturing Contract for Insmed’s ARIKAYCE™
04/29/2014
Therapure Biopharma Inc. Recognized for Innovation & Leadership at IAIR Awards in New York
04/22/2014
THERAPURE BIOPHARMA INC. HAS ACQUIRED PLASMA PROTEIN PURIFICATION TECHNOLOGY FROM UPFRONT CHROMATOGRAPHY A/S
12/03/2013
Therapure Biopharma Inc. wins a 2013 CMO Leadership Award in All 5 Categories: Quality, Reliability, Innovation, Productivity and Regulatory
09/11/2013
Therapure Biopharma Inc. Awarded US Government Contract for Development of Anti-Nerve Gas Agent
06/11/2013
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »